<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02648412</url>
  </required_header>
  <id_info>
    <org_study_id>Pupillo ketamine</org_study_id>
    <nct_id>NCT02648412</nct_id>
  </id_info>
  <brief_title>Pupillary Dilation After Incremental Tetanic Stimulations Under Ketamine Sedation</brief_title>
  <official_title>Pupillary Diameter Variation After Standardized Tetanic Stimulations of Incremental Intensities in Patients Under Ketamine Sedation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pr Isabelle CONSTANT</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hôpital Armand Trousseau</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study was to describe the relationship between the intensity of a standardized
      tetanic stimulation and the associated reflex pupillary dilation in patients under ketamine
      sedation.

      After an intravenous bolus of 1 mg/kg of ketamine, tetanic stimulations were performed every
      minute at increasing intensities of 10, 20, 30, 40 and 60 milliamps (similar to the
      stimulations of neuromuscular blocking agents monitoring). Pupillary diameter was measured
      before and after each stimulation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pupillary dilation: difference between post- and pre-stimulation pupillary diameter assessed by videopupillometry</measure>
    <time_frame>30 seconds after each stimulation (6 stimulations per patient)</time_frame>
    <description>Non-invasive measurement of pupillary diameter using an infrared camera, for each of the 6 stimulations per patient</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate variation</measure>
    <time_frame>30 seconds after each stimulation</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Pain</condition>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Ketamine sedation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Procedure scheduled under ketamine sedation. Baseline pupillary diameter measurement in alert subjects. Injection of a bolus of 1 mg/kg of ketamine. Every minute, tetanic stimulations of incremental intensities (10-20-30-40-60 milliamps), during 5 seconds.
Pupillary diameter measurement before and after each stimulation. End of study period, beginning of procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ketamine</intervention_name>
    <description>bolus 1 mg/kg</description>
    <arm_group_label>Ketamine sedation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tetanic stimulations of incremental intensities</intervention_name>
    <description>10-20-30-40-60 milliamps on the patient's left forearm</description>
    <arm_group_label>Ketamine sedation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient admitted to pediatric burns care unit

          -  Burnt skin area 5-40%

          -  Scheduled for a dressing change under ketamine sedation

        Exclusion Criteria:

          -  Neurologic or ophthalmic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Isabelle Constant, PHD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital Armand Trousseau</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Departement d'anesthesie Hopital Armand Trousseau</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 4, 2016</study_first_submitted>
  <study_first_submitted_qc>January 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2016</study_first_posted>
  <last_update_submitted>December 21, 2016</last_update_submitted>
  <last_update_submitted_qc>December 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hôpital Armand Trousseau</investigator_affiliation>
    <investigator_full_name>Pr Isabelle CONSTANT</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

